Stock Analysis

BlackRock (BLK): Valuation Check as New Systematic Alternatives ETF Extends Its Liquid Alts Toolkit

BlackRock (BLK) just added another piece to its ETF toolkit with the iShares Systematic Alternatives Active ETF, extending its lead in liquid alternatives as investors hunt for smoother, less market tied return streams.

See our latest analysis for BlackRock.

All of this product activity, from outcome focused income ETFs to liquid alternatives like IALT, comes as BlackRock’s 1 year total shareholder return of 3.78 percent lags its powerful 3 year total shareholder return of 63.68 percent. This suggests long term momentum remains intact even as the recent 90 day share price return of minus 4.48 percent hints at cooling sentiment around the current $1083.36 level.

If BlackRock’s ETF moves have you thinking more broadly about where capital is flowing, it might be worth exploring fast growing stocks with high insider ownership as a way to spot under the radar compounders.

With growth still in double digits and the share price sitting roughly 23 percent below the average analyst target, is BlackRock quietly undervalued here, or are investors already paying up for its next leg of earnings growth?

Most Popular Narrative: 18.5% Undervalued

With BlackRock last closing at $1083.36 against a narrative fair value near $1328.64, the story leans toward upside rooted in long term earnings power.

The company's global platform and targeted expansion in emerging markets (e.g., India and Middle East) align with the continued growth in global wealth and the investable asset base, supporting AUM growth and future fee accretion as capital markets and retirement systems develop in these regions.

Read the complete narrative.

Curious how steady double digit growth, thicker margins, and a lower future earnings multiple can still point higher from here? The full narrative unpacks the math.

Result: Fair Value of $1328.64 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, persistent fee compression and integration risks from recent private market acquisitions could cap margin expansion and challenge the long term undervaluation case.

Find out about the key risks to this BlackRock narrative.

Another Lens on Valuation

While the narrative fair value pegs BlackRock as 18.5 percent undervalued, its 27.6 times price to earnings looks rich versus the US capital markets average of 25.8 times and a fair ratio of 19.5 times. This implies meaningful de rating risk if sentiment cools.

See what the numbers say about this price — find out in our valuation breakdown.

NYSE:BLK PE Ratio as at Dec 2025
NYSE:BLK PE Ratio as at Dec 2025

Build Your Own BlackRock Narrative

If you see the story differently or want to dig into the numbers yourself, you can build a personalized view in just minutes: Do it your way.

A great starting point for your BlackRock research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.

Looking for more investment ideas?

Do not stop at BlackRock when the market is full of potential, use the Simply Wall Street Screener to pinpoint your next high conviction opportunity today.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Mobile Infrastructure for Defense and Disaster

The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.

Get the investor briefing before the next round of contracts

Sponsored On Behalf of CiTech

Valuation is complex, but we're here to simplify it.

Discover if BlackRock might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NYSE:BLK

BlackRock

A publicly owned investment manager.

Established dividend payer with adequate balance sheet.

Weekly Picks

WO
MGPI logo
woodworthfund on MGP Ingredients ·

THE KINGDOM OF BROWN GOODS: WHY MGPI IS BEING CRUSHED BY INVENTORY & PRIMED FOR RESURRECTION

Fair Value:US$4034.1% undervalued
22 users have followed this narrative
2 users have commented on this narrative
5 users have liked this narrative
DO
Double_Bubbler
EVTL logo
Double_Bubbler on Vertical Aerospace ·

Why Vertical Aerospace (NYSE: EVTL) is Worth Possibly Over 13x its Current Price

Fair Value:US$6089.9% undervalued
22 users have followed this narrative
3 users have commented on this narrative
17 users have liked this narrative
TI
TickerTickle
ORCL logo
TickerTickle on Oracle ·

The Quiet Giant That Became AI’s Power Grid

Fair Value:US$389.8149.0% undervalued
43 users have followed this narrative
4 users have commented on this narrative
8 users have liked this narrative

Updated Narratives

IM
HOH logo
Imthetxarbi on High Arctic Overseas Holdings ·

Deep Value Multi Bagger Opportunity

Fair Value:CA$471.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AG
Agricola
EXN logo
Agricola on Excellon Resources ·

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Fair Value:CA$31.898.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ST
stuart_roberts
UNCY logo
stuart_roberts on Unicycive Therapeutics ·

Unicycive Therapeutics (Nasdaq: UNCY) – Preparing for a Second Shot at Bringing a New Kidney Treatment to Market (TEST)

Fair Value:US$21.5370.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TH
TheWallstreetKing
MVIS logo
TheWallstreetKing on MicroVision ·

MicroVision will explode future revenue by 380.37% with a vision towards success

Fair Value:US$6098.4% undervalued
120 users have followed this narrative
11 users have commented on this narrative
22 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$250.3927.7% undervalued
963 users have followed this narrative
6 users have commented on this narrative
25 users have liked this narrative
RO
RockeTeller
SCZ logo
RockeTeller on Santacruz Silver Mining ·

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fair Value:CA$8688.0% undervalued
78 users have followed this narrative
8 users have commented on this narrative
21 users have liked this narrative